Gerhart Griss, Deceased

Title: Gerhart Griss: A Legacy of Innovation in Pharmacology

Introduction

Gerhart Griss was a notable inventor whose contributions to pharmacology have left a lasting impact. He was based in Biberach, Germany, and held a total of 7 patents during his career. His work primarily focused on the development of compounds with significant pharmacological properties.

Latest Patents

One of his latest patents involved phenylacetic acid benzylamides. This application relates to the uses of phenylacetic acid benzylamides and new (S)(+)-2-ethoxy-4-[N-[1-2-piperidino-phenyl)-3-methyl-1-butyl]-aminocarbonylmethyl]-benzoic acid and the salts thereof. These compounds are noted for their valuable pharmacological properties, particularly their effect on intermediate metabolism and their ability to lower blood sugar levels.

Career Highlights

Throughout his career, Gerhart Griss worked with prominent companies in the pharmaceutical industry. He was associated with Dr. Karl Thomae GmbH and Boehringer Ingelheim KG, where he contributed to various innovative projects. His work in these organizations helped advance the field of pharmacology and improve therapeutic options for patients.

Collaborations

Gerhart Griss collaborated with several notable individuals in his field, including Rudolf Hurnaus and Walter Kobinger. These collaborations fostered an environment of innovation and creativity, leading to significant advancements in pharmacological research.

Conclusion

Gerhart Griss's contributions to pharmacology and his innovative spirit have made a lasting impact on the industry. His work continues to influence the development of new therapeutic agents today.